October 2014

Helpful tips and articles about lung disease management.

Greetings,

With fall finally upon us, we set our sights on the upcoming holiday season and staying healthy during this time of year. At the Lung Institute, we are often asked about stem cell therapy and how it can help treat lung disease. With that in mind and after the success of our first stem cell therapy seminar, the Lung Institute will be holding another “Stem Cell Therapy Seminar” this month. With a presentation, come learn about our innovative treatment and what it can do for you. Find out more about this event here.

We are also excited to share some great news with you this month! On October 20, we opened our second clinic in Nashville, Tennessee. This new expansion will provide patients with another location to get state-of-the-art stem cell treatments for their lung disease closer to home.

Speaking of stem cell treatments, there are many in the field of medicine that believe stem cells are the future of the medical field. In a post from the blog, we discuss the future of stem cell therapy and how doctors will be applying these techniques to treat patients in the years to come.

And lastly, we are always thrilled to hear from current and former patients about their experiences at the Lung Institute. If you have been treated here and are willing to share your story, we would love to feature you in a future newsletter or on our website. Contact us today at info@lunginstitute.com.

Helping you to breathe easier,

The Lung Institute Team


From the blog:From the website:

The Lung Institute opened its doors to a new clinic in Nashville. With Nashville being a hub for medical technology, this was a prime location to expand to. The new clinic was marked by an official ribbon cutting ceremony from the medical staff, the corporate team, and members of the Nashville Chamber of Commerce.

Learn more about our expansion!

 



From the website:From the blog:

There are many in the field of medicine that believe stem cells are the future. Some doctors and researchers have gone on to say that the future is bright for stem cell research. Minus some drawbacks, it has only been within the last several years that research has provided more understanding into the wide range of uses for stem cells. With the amount of information that we have seen so far about stem cell therapy, it brings into question, what exactly is the future of stem cell therapy?

Find out here.

 

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.